Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Great themes in news release - beautiful

<< Previous

Bullboard Posts

Next >>

Comment by gainwidpatienceon May 11, 2020 9:56am

74 Views

Post# 31011343

RE:RE:RE:RE:RE:RE:RE:RE:Great themes in news release - beautiful

Issue is not with AmnioBoost.. but with CEO and their communication. The way they have managed the communication with shareholders.. reflected their helplessness. Look at the risk factors highlighted in NR.. it was not necessary at all. Same risk factors applies for SZLS.. but look at their NR's, it reflects lot of confidence in getting the work done piece by piece, not thinking how big the work is.

Need strong person in LBL management with Capital Market exposure.

Having said that anything low today I am going to add.. for me it's a bottom. If their study becomes successful, there will be lot of eyes here from big pharma companies. They might help these guyz for further trials.

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver